» Articles » PMID: 23625211

Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part II

Overview
Journal Eur Heart J
Date 2013 Apr 30
PMID 23625211
Citations 168
Authors
Affiliations
Soon will be listed here.
Abstract

In part II of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. Specifically, evidence-based cardiovascular therapies are discussed through novel clinical insights on management of hyperglycaemia, hypertension, dyslipidaemia as well as platelet dysfunction. Recent trends in the incidence and outcomes of vascular disease in diabetes suggest that timely and effective implementation of therapies is making a favourable impact.

Citing Articles

Investigation of the Zingerone's effects on wound healing in induced diabetic rats model.

Mokhtare B, Saglam Y Arch Dermatol Res. 2025; 317(1):484.

PMID: 39994064 DOI: 10.1007/s00403-025-03924-6.


A meta-analysis examining the impact of prostaglandins on diabetic nephropathy.

Guo X Int Urol Nephrol. 2025; .

PMID: 39971865 DOI: 10.1007/s11255-025-04424-2.


Fractional flow reserve- and intravascular ultrasound-guided strategies for intermediate coronary stenosis and low lesion complexity in patients with or without diabetes: a post hoc analysis of the randomised FLAVOUR trial.

Cho S, Kang J, Zhang J, Hu X, Hwang J, Kwak J EuroIntervention. 2025; 21(3):e183-e192.

PMID: 39901633 PMC: 11776404. DOI: 10.4244/EIJ-D-24-00589.


Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study.

Li Z, Yu C, Zhang H, Chen R, Zhao Y, Zheng Z Cardiovasc Diabetol. 2025; 24(1):8.

PMID: 39780174 PMC: 11708299. DOI: 10.1186/s12933-024-02537-z.


Association of non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio with cardiovascular outcomes in patients with type 2 diabetes mellitus: Evidence from the ACCORD cohort.

Liu M, Pei J, Zeng C, Xin Y, Zhang Y, Tang P Diabetes Obes Metab. 2024; 27(1):300-311.

PMID: 39415313 PMC: 11618286. DOI: 10.1111/dom.16018.